Background: Researchers proved the association between inflammatory condition, high sensitive C reactive protein (hs-CRP), and cardiovascular diseases (CVDs) in type 2 diabetes mellitus (DM). Therefore, this study aimed to assess the hs-CRP level in type 2 DM patients and their relation to diabetes cardiovascular complications.
insulin action. [1] [2] [3] . Recently, DM become the most common chronic disorder, (4) with increasing prevalence worldwide (5) . It was estimated that 425 million people had DM in 2017, and the number is expected to rise to 629 million by 2045 [6] . In Sudan, the prevalence of DM is rising from 9.3% in 2010 to 10.6 % in four states in 2013 [7] . Type 2 diabetes mellitus is a complex condition, results from the resistance of insulin action combined with impaired pancreatic function [8] . If left uncontrolled, Type 2 DM can cause chronic microvascular and macrovascular complications [9] . Some previous studies confirmed that Type 2 DM gradually causes chronic low-grade inflammation, which plays a vital role in the progression of diabetic complications [10] .
Type 2 DM patients are at a high risk to develop CVDs, and the risk increased when patients suffer from nephropathy [11] . The CVDs are observed to increase in type 2 DM with elevated inflammatory markers [12] . The inflammatory marker hs-CRP is a pentameric protein synthesized by hepatic cells under the control of cytokines [11] . It has been identified as a reliable predictor marker for CVDs [13] [14] [15] . Previous studies documented that, diabetic patients undergo high serum hs-CRP level [16] , that lead to the activation of inflammatory pathways and progression of CVD [17, 18] . Accordingly, this study was conducted to determine whether the hs-CRP is associated with CVDs in type 2 DM patients.
Materials and Methods
This case-control study was conducted in the Military Hospital at Khartoum state during period from 2015 to 2019. Randomly 205 type 2 DM patients (111 females and 94 males), and 100 apparently healthy control matched in age and gender were selected. DM patients with inflammatory, liver, and/or renal diseases were excluded. After written informed consents, 5 ml venipuncture blood was collected. The study was approved by the local committee of Al-Neelain University, Sudan (issued in May 2015).
Measurement of BMI
Body mass index (BMI) was calculated using (weight kg/hight m 2 ) formula.
Measurement of hs-CRP
Serum level of hs-CRP were measured by Cobas C-311 ® (Roche Diagnostics, Germany) using the Particle enhanced immunoturbidimetric method Human CRP agglutinates with latex particles coated with monoclonal anti-CRP antibodies, and then the precipitate was determined turbidimmetrically.
Measurement of lipid profile
Serum TG, TG, and HDL-cholesterol were estimated by Cobas C-311 ® automated chemistry analyzer (Roche Diagnostics, Germany).
TG measurement
Using the principle enzymatic colorimetric method which based on complete hydrolysis of triglycerides by lipoprotein lipase to glycerol, followed by oxidation and peroxidation process to form a red dyestuff. The color intensity of the red dyestuff formed is directly proportional to the triglyceride concentration and can be measured photometrically.
TC measurement
Estimation of total cholesterol based on serial enzymatic reactions leads to the formation of red quinone-imine dye, which can be measured photometrically. The color intensity of the dye formed is directly proportional to the cholesterol concentration.
HDL-C measurement
In the presence of magnesium ions, dextran sulfate selectively forms water-soluble complexes with LDL, VLDL, and chylomicrons. The cholesterol concentration of HDLcholesterol is determined enzymatically after the formation of a purple-blue dye. The color intensity of this dye is directly proportional to the cholesterol concentration and is measured photometrically.
LDL-C measurement
Levels of LDL-C were calculated using the Friedwald equation [19] as follow:
Statistical analysis
All statistical analyses were performed using the SPSS software (Statistical Package for the Social Sciences) (version 21.0; SPSS Inc.). Descriptive statistic (frequency and percentage) were obtained. Independent t-test was employed to compare mean between groups. Pearson's correlation was used to correlate between study parameters and variables. Quantitative variables were demonstrated as mean±SD; significant differences were considered as P-value ≤ 0.05.
Results
The study comprised of 205 Type 2 diabetic patients and 100 subjects as control. The demographic and general characteristics of the population are shown in ( Table 1 ).
The mean level of hs-CRP was significantly increased in the diabetic group Table 2) .
The results of the study showed the mean level of hs-CRP was significantly higher in female (5.91±2.61) compared with male (3.54±2.55) with (p-value 0.005). Furthermore, the lipid profile results showed a significant increase in TC, HDL-C, and LDL-C mean levels in female compared with male (p-value 0.000) as shown in (Table 3) .
Patients group who take cholesterol-lowering agent (statin) had significantly lower levels of hs-CRP, TC and LDL-C as compared with untreated Patients (p-value 0.030, 0.000 and 0.000, respectively), while other parameter showed insignificant differences between two groups (Table 4 ).
In correlation analysis, hs-CRP level correlates positively with BMI (r: 0.56 p-value 0.000), while no correlation observed according to age, duration of disease and lipid profile as in (Table 5 ). The results expressed as (Mean±SD) and P value less than 0.05 was considered statistically significant. The results expressed as (Mean±SD) and P-value less than 0.05 was considered statistically significant. The results expressed as (Mean±SD) and P-value less than 0.05 was considered statistically significant. 
Discussion
In this study, we found that type 2 DM is prevalent in females than males. The predominance of females with diabetes is attributed to the hormonal effects, the higher ability of the body to store iron and physical inactivity; indeed, most of them were housewives [20] . In our study, the majority of patients are elderly and overweight. Thus postulated combination of genetic predisposition, environmental, nutritional factors, obesity, physical inactivity, stress, and aging [21] , might be involved in Sudanese type2 DM. Moreover, patients personal data revealed low to moderate education and socioeconomic status.
A previous study observed low educational level correlate with DM, and socioeconomic status inversely associated with DM prevalence [22] .
Serum hs-CRP level was significantly higher in type 2 DM patients than non diabetic group. This finding in agreement with the previous study that, pro-inflammatory cytokine hs-CRP was significantly higher in type 2 diabetic patients [23, 24] . Recently, the inflammatory pathway plays a critical role in type 2 pathogenesis, development, and progression of diabetes complications [11] . On the other hand, in accordance with previous reports [25, 26] , we found that women had higher hs-CRP levels than with men. In fact that gender difference has not yet completely understood, many studies speculated that adiposity, hormones replacement therapy, postmenopausal are associated with higher levels of CRP in women [26] .
Furthermore, female type 2 DM patients had higher levels of TC, HDL-C, and LDL-C than the diabetic males which is in line with previous studies [27] . The findings may attributed to the effect of sex hormones and distribution of body fat leading to these differences [27] . Moreover, patients who received Statin treatment revealed lower levels of hs-CRP, TC, and LDL-C. A previous evidence suggest that, therapy with atorvastatin lead to reduced hs-CRP and LDL-C levels in patients with type 2 DM [28] .
Likewise, previous reports revealed proportional association between hs-CRP level and BMI [29] , our study showed a positive relationship between hs-CRP and BMI.
Meanwhile, no correlations noted with lipid profile. Since CRP used to predict CVDs even in patients with low LDL-C, indeed its stability in blood and not affecting by food intake [30] .
The limitations of this study are frist the number controls is not equal to patients.
Second there are no pre-investigations done to patients, therefore the selection depend on previous clinical investigation.
Conclusion
The study concludes that, the hs-CRP level is increased in type 2 DM patients. Females had higher hs-CRP than males. Furthermore, atorvastatin reduces hs-CRP level. Also, hs-CRP correlates positively with BMI Therefore, monitoring of hs-CRP is recommended, especially for females, overweight and obese type 2 DM patients, consequently early intervention.
